Lobe-Specific Lymph Node Dissection May be Feasible for Clinical N0 Solid-Predominant Part-Solid Lung Adenocarcinoma With Solid Component Diameter ≤ 2 cm-Reference-Cited by-同舟云学术

Lobe-Specific Lymph Node Dissection May be Feasible for Clinical N0 Solid-Predominant Part-Solid Lung Adenocarcinoma With Solid Component Diameter ≤ 2 cm

Published:2023-07 Issue:5 Volume:24 Page:437-444
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Wo Yang,Li Hang,Chen Zhencong,Peng Yizhou,Zhang Yang,Ye Ting,Jiang Wei,Sun Yihua

Funder

Science and Technology Commission of Shanghai Municipality

Beijing Xisike Clinical Oncology Research Foundation

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. the international association for the study of lung cancer lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer;Asamura;J Thorac Oncol,2015

2. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines;Howington;Chest,2013

3. Lobe-specific lymph node dissection as a standard procedure in surgery for non-small cell lung cancer: a propensity score matching study;Adachi;J Thorac Oncol,2017

4. Tumor histology predicts mediastinal nodal status and may be used to guide limited lymphadenectomy in patients with clinical stage I non-small cell lung cancer;Cheng;J Thorac Cardiovasc Surg,2018

5. Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer;Shapiro;Chest,2013